ZNF354A Activators are a diverse array of chemical compounds that influence various signaling pathways and cellular processes to enhance the functional activity of the transcription factor ZNF354A. Compounds like Forskolin and Isoproterenol elevate intracellular cAMP levels, activating PKA which can phosphorylate substrates that cooperate with ZNF354A, thereby enhancing its transcriptional activity. Similarly, the use of db-cAMP, a stable cAMP analog, leads to sustained PKA activation with comparable outcomes. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which can also phosphorylate proteins that modulate ZNF354A activity, while A23187 and Ionomycin increase intracellular calcium levels, potentially affecting calcium-dependent signaling pathways that enhance ZNF354A's DNA-binding activity. Spermine, by modulating chromatin structure, can improve ZNF354A's access to DNA, facilitating its regulatory functions. Epigallocatechin gallate (EGCG) acts as a kinase inhibitor, which might enhance ZNF354A's functionality by decreasing competitive phosphorylation of transcription factors.
Retinoic acid influences nuclear receptors that could heterodimerize withZNF354A or modulate ZNF354A's target genes, thereby enhancing its transcriptional efficacy through co-regulatory interactions. Histone deacetylase inhibitors, such as Trichostatin A (TSA) and Sodium butyrate, induce a more relaxed chromatin state, which can enhance the binding of ZNF354A to DNA and its subsequent transcriptional regulation. LY294002, a PI3K inhibitor, could modify downstream signaling in a way that affects the phosphorylation status of ZNF354A or its associated proteins, thereby influencing ZNF354A's activity in gene regulation. Collectively, these activators utilize a variety of intracellular modifications to enhance the activity of ZNF354A, ranging from direct influences on chromatin accessibility and DNA binding to the modulation of signaling pathways that converge on the transcriptional machinery ZNF354A is part of. Through these mechanisms, ZNF354A activators exert their effect, ensuring that ZNF354A can more efficiently fulfill its role as a regulator of gene expression.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trehalose, Dihydrate | 6138-23-4 | sc-202368 sc-202368A | 50 g 500 g | $60.00 $223.00 | 6 | |
Trehalose activates ZNF354A by promoting cellular stress adaptation. Trehalose acts as a chemical chaperone, stabilizing protein structure and function under stress conditions. This stabilization activates ZNF354A, leading to enhanced transcriptional activity and gene expression. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol activates ZNF354A by modulating beta-adrenergic signaling pathways. Propranolol inhibits beta-adrenergic receptors, leading to the activation of downstream effectors, including ZNF354A. Activation of ZNF354A enhances its transcriptional activity and promotes gene expression. | ||||||